Maravai Life Sciences
San Diego
About Maravai Life Sciences
Maravai LifeSciences was formed in March 2014 as a partnership among Carl Hull and Eric Tardif -- proven leaders in the life sciences industry -- and GTCR, a leading private equity firm. Maravai’s mission is to build a transformative life sciences products company by acquiring outstanding businesses and accelerating their growth. They do this through direct cash investments in their existing operations, by acquiring complementary businesses or product lines and by contributing our proven operating expertise.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 501 – 1,000
- Estimated revenue: $100K – $500K
- Total funding: $1.0B
- Funding stage: IPO
- Last round: Post-IPO Equity (Sep 2021)
- Ticker: nasdaq:MRVI
- Website: maravai.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/maravai-life-sciences-150067 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.